Patents by Inventor Waleed M. ALGHAMDI

Waleed M. ALGHAMDI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11979408
    Abstract: In an example method, a system obtains a data record indicating an anticipated change in an employment status of a user at an organization, including a data field indicating an effective time of the anticipated change. At a first time prior to the effective time, the system modifies an access privilege of the user with respect to computer resources of the organization, including (i) allowing the user to perform first operations using the computer resources between the first time and a second time subsequent to the first time, and (ii) preventing the user from performing second operations using the computer resources starting at the first time. At the second time, the system further modifies the access privilege of the user, including preventing the user from performing the operations using the computer resources starting at the second time.
    Type: Grant
    Filed: November 15, 2021
    Date of Patent: May 7, 2024
    Assignee: Saudi Arabian Oil Company
    Inventors: Abdullah Tariq Al-Essa, Khalid H. Qahtani, Norah A. Yousif, Waleed A. Alamri, Tariq S. Alshlash, Lamia M. Mugla, Fahd S. Alghamdi
  • Publication number: 20230248659
    Abstract: An immune-suppressing nanoparticle (NP) decorated with alpha-1 acid glycoprotein (AGP), an anti-inflammatory protein, circumventing the resistance of breast tumor cells to chemotherapy in addition to suppressing the tumor metastasis and invasion is disclosed. Methods of making hyaluronic acid-chitosan nanoparticles decorated with AGP (AGP-HA NPs) by sequential ionic gelation, spray drying, and AGP-surface adsorption are also disclosed. Treatment options to strengthen the anti-cancer effects of chemotherapeutic agents and potentially improve the survival rate of patients with metastatic breast cancer using the disclosed AGP-HA NPs containing agents are also disclosed.
    Type: Application
    Filed: October 19, 2022
    Publication date: August 10, 2023
    Inventors: Ali H. ALHASAN, Haneen OMAR, Roa' FARDOUS, Yasser ALHINDI, Abdulaziz ALMALIK, Waleed M. ALGHAMDI